Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.

Literature DB >> 21984744

Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.

Tathagata Mukherjee, Helena Boshoff, Clifton E Barry.

Abstract

Entities: Species

Mesh：

Substances：
Antitubercular Agents

Year: 2011 PMID： 21984744 PMCID： PMC3236054 DOI： 10.1093/jac/dkr418

Source DB: PubMed Journal: J Antimicrob Chemother ISSN： 0305-7453 Impact factor: 5.790

× No keyword cloud information.

13 in total

Review 1. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors: David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal: Am J Respir Crit Care Med Date: 2007-02-15 Impact factor: 21.405

2. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.

Authors: C K Stover; P Warrener; D R VanDevanter; D R Sherman; T M Arain; M H Langhorne; S W Anderson; J A Towell; Y Yuan; D N McMurray; B N Kreiswirth; C E Barry; W R Baker
Journal: Nature Date: 2000-06-22 Impact factor: 49.962

3. Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.

Authors: Sidharth Chopra; Karen Matsuyama; Christopher Hutson; Peter Madrid
Journal: J Antimicrob Chemother Date: 2011-04-11 Impact factor: 5.790

Review 4. Helicobacter pylori: new developments and treatments.

Authors: S J Veldhuyzen van Zanten; P M Sherman; R H Hunt
Journal: CMAJ Date: 1997-06-01 Impact factor: 8.262

5. Metronidazole: review of uses and toxicity.

Authors: F J Roe
Journal: J Antimicrob Chemother Date: 1977-05 Impact factor: 5.790

6. Interaction of metronidazole with DNA repair mutants of Escherichia coli.

Authors: T C Yeung; B B Beaulieu; M A McLafferty; P Goldman
Journal: Antimicrob Agents Chemother Date: 1984-01 Impact factor: 5.191

7. The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes.

Authors: E Perez-Reyes; B Kalyanaraman; R P Mason
Journal: Mol Pharmacol Date: 1980-03 Impact factor: 4.436

8. Identification of Mycobacterium species by secA1 sequences.

Authors: Adrian M Zelazny; Leslie B Calhoun; Li Li; Yvonne R Shea; Steven H Fischer
Journal: J Clin Microbiol Date: 2005-03 Impact factor: 5.948

9. Isolation of the Helicobacter pylori recA gene and involvement of the recA region in resistance to low pH.

Authors: S A Thompson; M J Blaser
Journal: Infect Immun Date: 1995-06 Impact factor: 3.441

10. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.

Authors: L G Wayne; H A Sramek
Journal: Antimicrob Agents Chemother Date: 1994-09 Impact factor: 5.191

4 in total

Review 1. Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities.

Authors: Anna Egorova; Mary Jackson; Victor Gavrilyuk; Vadim Makarov
Journal: Med Res Rev Date: 2021-03-01 Impact factor: 12.388